Detalles de la búsqueda
1.
Serum Cytokines Correlate with Pretreatment Body Mass Index-adjusted Body Weight Loss Grading and Cancer Progression in Patients with Stage III Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery.
Nutr Cancer
; 76(6): 486-498, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680010
2.
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.
Int J Cancer
; 152(6): 1191-1201, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346116
3.
Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report.
Int J Mol Sci
; 24(15)2023 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37569525
4.
Pretreatment Nutrition-Inflammation Biomarkers Correlated with Differential Cytokine Profiles in Taiwanese Patients with Colorectal Cancer.
Nutr Cancer
; 74(5): 1614-1624, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323132
5.
Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Cancer Control
; 29: 10732748211045276, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994207
6.
Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer.
BMC Cancer
; 21(1): 908, 2021 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376155
7.
Body Mass Index-Adjusted Body Weight Loss Grading Predicts Overall Survival in Esophageal Squamous Cell Carcinoma Patients.
Nutr Cancer
; 73(7): 1130-1137, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32664752
8.
A comparison of the MNA-SF, MUST, and NRS-2002 nutritional tools in predicting treatment incompletion of concurrent chemoradiotherapy in patients with head and neck cancer.
Support Care Cancer
; 29(9): 5455-5462, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704566
9.
A prospective nutritional assessment using Mini Nutritional Assessment-short form among patients with head and neck cancer receiving concurrent chemoradiotherapy.
Support Care Cancer
; 29(3): 1509-1518, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710174
10.
External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience in Taiwan.
Pancreatology
; 20(1): 116-124, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711795
11.
Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy.
J Gastroenterol Hepatol
; 35(10): 1694-1703, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711261
12.
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
BMC Cancer
; 19(1): 1167, 2019 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791269
13.
Prognostic Significance of Low Body Mass Index and Betel-Quid Use in the 5-Year Survival Rates of Esophageal Squamous Cell Carcinoma Patients.
Nutr Cancer
; 70(8): 1315-1321, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900908
14.
Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.
Chin J Cancer Res
; 29(3): 172-178, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729767
15.
The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.
BMC Palliat Care
; 14: 18, 2015 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924723
16.
The Charlson Comorbidity Index is an Independent Prognostic Factor for Treatment-Naïve Hepatocellular Carcinoma Patients with Extrahepatic Metastases.
Hepatogastroenterology
; 62(140): 1011-5, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26902047
17.
Dasatinib-related chylothorax.
Turk J Haematol
; 32(1): 68-72, 2015 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25805678
18.
Successful rechallenge of cetuximab following severe infusion-related reactions: a case report.
Chin J Cancer Res
; 26(1): E10-2, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24653637
19.
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy.
Cancers (Basel)
; 16(5)2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473256
20.
Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
Adv Sci (Weinh)
; 11(11): e2306373, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38204202